Indian drugmaker Aurobindo Pharmaceuticals has offered to supplyMedecins Sans Frontieres with its three-drug HIV/AIDS cocktail for approximately $295 per patient per year (Marketletter June 4).
Indian firms Cipla and Hetero Drugs supply MSF with an identical AIDS package at $350 and $347 respectively per patient per year (Marketletter June 18), notes India's Financial Express. Aurobindo director Lanka Srinivas said the offer has already been made to MSF and other groups. "We are also keen on making supplies to the government programs, and our products are being registered in most South African countries," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze